Jérôme Tiollier

MECHANISMS INVOLVED IN ANTITHYMOCYTE GLOBULIN IMMUNOSUPPRESSIVE ACTIVITY IN A NONHUMAN PRIMATE MODEL 1

Xavier Préville, Monique Flacher, BRIGITTE LEMAUFF et al. · Transplantation · 2001 · 279 citations

Life Sciences, Immunology, Pathobiology +17

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

Jaafar Bennouna, Emmanuelle Bompas, Eve Marie Neidhardt et al. · Cancer Immunology Immunotherapy · 2008 · 239 citations · Full text

Medicine, Immunology, Oncology +14

A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma

Don M. Benson, Craig C. Hofmeister, Attaya Suvannasankha et al. · Blood · 2012 · 238 citations · Full text

Medicine, Immunology, Oncology +10

In Vivo Immunomanipulation of Vγ9Vδ2 T Cells with a Synthetic Phosphoantigen in a Preclinical Nonhuman Primate Model

Hélène Sicard, Sophie Ingoure, Béatrice Luciani et al. · The Journal of Immunology · 2005 · 186 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute

Estelle Tinois, Jérôme Tiollier, M Gaucherand et al. · Experimental Cell Research · 1991 · 168 citations

Engineering, Cell Biology, Dermatology +17